Cargando…
A dual-specific CRISPR-Cas nanosystem for precision therapeutic editing of liver disorders
Autores principales: | Xu, Xiaojie, Tang, Honglin, Guo, Jiajing, Xin, Huhu, Ping, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372082/ https://www.ncbi.nlm.nih.gov/pubmed/35953473 http://dx.doi.org/10.1038/s41392-022-01071-2 |
Ejemplares similares
-
Genome-editing prodrug: Targeted delivery and conditional stabilization of CRISPR-Cas9 for precision therapy of inflammatory disease
por: Yan, Xiaojie, et al.
Publicado: (2021) -
Rational Design of Poly(disulfide)s as a Universal
Platform for Delivery of CRISPR-Cas9 Machineries toward Therapeutic
Genome Editing
por: Guo, Jiajing, et al.
Publicado: (2021) -
CRISPR/Cas9 Delivery Mediated with Hydroxyl‐Rich Nanosystems for Gene Editing in Aorta
por: Zhang, Xiaoping, et al.
Publicado: (2019) -
Inflammation conditional genome editing mediated by the CRISPR-Cas9 system
por: Yuan, Tingting, et al.
Publicado: (2023) -
Inflammation conditional genome editing mediated by the CRISPR-Cas9 system
por: Yuan, Tingting, et al.
Publicado: (2023)